tradingkey.logo

BRIEF-Bio-Path Provides Key Clinical Updates

ReutersFeb 13, 2025 1:05 PM

- Bio Path Holdings BPTH.O:

  • BIO-PATH HOLDINGS PROVIDES KEY CLINICAL UPDATES

  • BIO PATH HOLDINGS: REPORTS CONTINUED PATIENT PROGRESS FROM PHASE 2 TRIPLE COMBINATION STUDY OF PREXIGEBERSEN IN ACUTE MYELOID LEUKEMIA (AML)

Source text: ID:nGNX3SPmN1

Further company coverage: BPTH.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI